Insider Transactions Reported by 17 Insiders of Calithera Biosciences, Inc.

Location
South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 12 Feb 2025

Calithera Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
JONATHAN G. DRACHMAN Director $77,160 10 Nov 2021
Francesco Parlati Sr. Vp, Research $54,397 25 Jan 2022
Sumita Ray Svp, General Counsel & Chief Compliance Officer $40,509 25 Jan 2022
Keith Orford Director $25,499 01 Jun 2022
Susan Molineaux PRESIDENT & CEO, Director $14,609 23 Jan 2023
Christopher J. Molineaux Sr. Vp, Development $14,609 23 Jan 2023
Eric Sjogren Sr. Vp, Drug Discovery $3,267 23 Jan 2023
Stephanie Wong Chief Financial Officer & Secretary $2,565 23 Jan 2023
Emil Kuriakose Chief Medical Officer $1,365 23 Jan 2023
Henry Ward Wolff Director 01 Jun 2022
J. Scott Garland Director 01 Jun 2022
Blake Wise Director 01 Jun 2022
DEEPIKA PAKIANATHAN Director 27 Jan 2023
Jean George Director 11 Jun 2021
TAKEDA PHARMACEUTICAL CO LTD Former 10% Owner 17 Apr 2023
Suzy Jones Director 01 Jun 2022
SUNIL AGARWAL Director 01 Jun 2022

Recent Insider Transactions by Companies or Individuals for Calithera Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.